Related Experiment Videos
Vertebrobasilar thrombolysis with intravenous tirofiban: case report
David S Liebeskind1, John R Pollard, Eric D Schwartz
1Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104-4283, USA. davidliebeskind@yahoo.com
Journal of Thrombosis and Thrombolysis
|July 9, 2002
Abstract:
The use of thrombolytic agents in the setting of established cerebral infarction is limited by concerns for hemorrhagic transformation. Novel thrombolytic approaches, which have received minimal consideration, may be associated with lower risks of hemorrhage. We illustrate vertebrobasilar thrombolysis with intravenous tirofiban, a selective platelet glycoprotein IIb/IIIa receptor antagonist, and discuss the potential thrombolytic properties of this class of antithrombotics.